85 related articles for article (PubMed ID: 27633255)
1. miR-449 overexpression inhibits papillary thyroid carcinoma cell growth by targeting RET kinase-β-catenin signaling pathway.
Li Z; Huang X; Xu J; Su Q; Zhao J; Ma J
Int J Oncol; 2016 Oct; 49(4):1629-1637. PubMed ID: 27633255
[TBL] [Abstract][Full Text] [Related]
2. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
[TBL] [Abstract][Full Text] [Related]
3. Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation.
Cho NL; Lin CI; Whang EE; Carothers AM; Moore FD; Ruan DT
Thyroid; 2010 Jun; 20(6):615-22. PubMed ID: 20470206
[TBL] [Abstract][Full Text] [Related]
4. The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.
Castellone MD; De Falco V; Rao DM; Bellelli R; Muthu M; Basolo F; Fusco A; Gutkind JS; Santoro M
Cancer Res; 2009 Mar; 69(5):1867-76. PubMed ID: 19223551
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma.
Zhao Z; Yang F; Liu Y; Fu K; Jing S
Oncol Lett; 2018 Oct; 16(4):5237-5242. PubMed ID: 30250593
[TBL] [Abstract][Full Text] [Related]
6. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
8. Klotho Inhibits Proliferation in a RET Fusion Model of Papillary Thyroid Cancer by Regulating the Wnt/β-Catenin Pathway.
Wu Q; Jiang L; Wu J; Dong H; Zhao Y
Cancer Manag Res; 2021; 13():4791-4802. PubMed ID: 34168498
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
10. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M
Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606
[TBL] [Abstract][Full Text] [Related]
11. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
[TBL] [Abstract][Full Text] [Related]
12.
Yin Y; Hong S; Yu S; Huang Y; Chen S; Liu Y; Zhang Q; Li Y; Xiao H
Int J Endocrinol; 2017; 2017():6180425. PubMed ID: 28740507
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
[TBL] [Abstract][Full Text] [Related]
14. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2.
Hua K; Jin J; Zhang H; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 Oct; 49(4):1531-1540. PubMed ID: 27633373
[TBL] [Abstract][Full Text] [Related]
16. BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.
Mitsutake N; Miyagishi M; Mitsutake S; Akeno N; Mesa C; Knauf JA; Zhang L; Taira K; Fagin JA
Endocrinology; 2006 Feb; 147(2):1014-9. PubMed ID: 16254036
[TBL] [Abstract][Full Text] [Related]
17. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
[TBL] [Abstract][Full Text] [Related]
18. XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.
Lodyga M; De Falco V; Bai XH; Kapus A; Melillo RM; Santoro M; Liu M
Oncogene; 2009 Feb; 28(7):937-49. PubMed ID: 19060924
[TBL] [Abstract][Full Text] [Related]
19. Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway.
Luo NF; Li JL; Lv J; Chen FK; Li YN; Tang M; Liu PJ
Heliyon; 2024 Mar; 10(6):e27840. PubMed ID: 38545139
[TBL] [Abstract][Full Text] [Related]
20. miRNA-15a regulates the proliferation and apoptosis of papillary thyroid carcinoma via regulating AKT pathway.
Jin J; Zhang J; Xue Y; Luo L; Wang S; Tian H
Onco Targets Ther; 2019; 12():6217-6226. PubMed ID: 31496725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
